Treatment of inoperable large cell neuroendocrine lung cancer with single agent temozolomide

Authors

  • Annika Marie Ørting a Department of Oncology, Copenhagen University Hospital – Rigshospitalet, Kobenhavn, Denmark
  • Malene Martini Clausen a Department of Oncology, Copenhagen University Hospital – Rigshospitalet, Kobenhavn, Denmark; b ENETS European Neuroendocrine Tumor Center of Excellence, Rigshospitalet, Denmark; g Department of Clinical Physiology, Nuclear Medicine & PET and Cluster for Molecular Imaging, Copenhagen University Hospital – Rigshospitalet, Rigshospitalet, Denmark
  • Patrick Soldath b ENETS European Neuroendocrine Tumor Center of Excellence, Rigshospitalet, Denmark;c Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark;d Department of Cardiothoracic Surgery, Copenhagen University Hospital – Rigshospitalet, Rigshospitalet, Denmark
  • Rene H. Petersen b ENETS European Neuroendocrine Tumor Center of Excellence, Rigshospitalet, Denmark; c Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark; d Department of Cardiothoracic Surgery, Copenhagen University Hospital – Rigshospitalet, Rigshospitalet, Denmark
  • Ulrich Knigge b ENETS European Neuroendocrine Tumor Center of Excellence, Rigshospitalet, Denmark; e Department of Gastrointestinal Surgery, Copenhagen University Hospital – Rigshospitalet, Rigshospitalet, Denmark; f Department of Endocrinology, Copenhagen University Hospital – Rigshospitalet, Rigshospitalet, Denmark
  • Mikkel Andreassen b ENETS European Neuroendocrine Tumor Center of Excellence, Rigshospitalet, Denmark; c Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark; f Department of Endocrinology, Copenhagen University Hospital – Rigshospitalet, Rigshospitalet, Denmark
  • Andreas Kjær b ENETS European Neuroendocrine Tumor Center of Excellence, Rigshospitalet, Denmark;g Department of Clinical Physiology, Nuclear Medicine & PET and Cluster for Molecular Imaging, Copenhagen University Hospital – Rigshospitalet, Rigshospitalet, Denmark; h Department of Biomedical Science, University of Copenhagen, Copenhagen, Denmark
  • Seppo W. Langer a Department of Oncology, Copenhagen University Hospital – Rigshospitalet, Kobenhavn, Denmark; b ENETS European Neuroendocrine Tumor Center of Excellence, Rigshospitalet, Denmark; c Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark

DOI:

https://doi.org/10.1080/0284186X.2023.2258444

Abstract

No abstract available

Downloads

Download data is not yet available.

Downloads

Published

2023-12-02

How to Cite

Marie Ørting, A., Martini Clausen, M., Soldath, P., Petersen, R. H., Knigge, U., Andreassen, M., … Langer, S. W. (2023). Treatment of inoperable large cell neuroendocrine lung cancer with single agent temozolomide. Acta Oncologica, 62(12), 1952–1955. https://doi.org/10.1080/0284186X.2023.2258444

Issue

Vol. 62 No. 12 (2023): Acta Oncologica

Section

Articles